Papers - ASANO KENICHIRO
-
Giant cell glioblastoma is a distinctive subtype of glioma characterized by vulnerability to DNA damage.
Ogawa K, Kurose A, Kamataki A, Asano K, Katayama K, Kurotaki H
Brain tumor pathology 37 ( 1 ) 5 - 13 2020.1
-
A Case of Clear Cell Meningioma presenting with Intracranial Metastasis treated Operatively and by Gamma Knife Radiosurgery
Sasaki Takao, Asano Kenichiro, Kakuta Kiyohide, Katayama Kosuke, Okuma Hiroki, Kurose Akira
Japanese Journal of Neurosurgery 29 ( 10 ) 718 - 725 2020
-
Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group
ONO Takahiro, FUJII Yukihiko, OHKUMA Hiroki, OGASAWARA Kuniaki, SONODA Yukihiko, SAITO Kiyoshi, NOBUSAWA Sumihito, NAKAZATO Yoichi, KITANAKA Chifumi, KAYAMA Takamasa, TOMINAGA Teiji, SASAJIMA Toshio, For the Tohoku Brain Tumor Study Group, SHIMIZU Hiroaki, NATSUMEDA Manabu, KANAMORI Masayuki, ASANO Kenichiro, BEPPU Takaaki, MATSUDA Kenichiro, ICHIKAWA Masahiro
Neurologia medico-chirurgica 60 ( 11 ) 543 - 552 2020
-
ACCURACY OF INTRAOPERATIVE SIMPLE FLOW CYTOMETER FOR HIGH GRADE GLIOMA OPERATION COMPARED WITH INTRAOPERATIVE FROZEN DIAGNOSIS.
Asano K, Fumoto T, Kamataki A, OgawaK, Kakuta K, Katayama K, Ohkuma H, Kurose A.
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii24 2019.12
-
Retrieving Elderly Patients with Subarachnoid Hemorrhage from Frailty
SHIMAMURA Norihito, OKUMA Hiroki, NARAOKA Masato, MATSUDA Naoya, KATAYAMA Kosuke, KAKUTA Kiyohide, KATAGAI Takeshi, FUJIWARA Nozomi, ITO Katsuhiro, ASANO Kenichiro
Surgery for Cerebral Stroke 47 ( 2 ) 115 - 120 2019
-
＜一般演題抄録＞津軽地域における急性期脳虚血再灌流療法の現状と課題
嶋村 則人, 奈良岡 征都, 片山 耕輔, 角田 聖英, 片貝 武, 藤原 望, 松田 尚也, 浅野 研一郎, 大熊 洋揮
弘前医学 70 ( 1 ) 96 - 96 2019
-
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. 2018.7
-
The effect of goreisan on the prevention of chronic subdural hematoma recurrence - multicenter, randomized controlled study.
Katayama K, Matsuda N, Kakuta K, Naraoka M, Takemura A, Hasegawa S, Akasaka K, Shimamura N, Itoh K, Asano K, Hiromu K, Ohkuma H.
J Neurotrauma. 2018.7
-
Importance and accuracy of intraoperative frozen section diagnosis of the resection margin for effective carmustine wafer implantation.
Asano K, Kurose A, Kamataki A, Kato N, Ogawa K, Katayama K, Kakuta K, Fumoto T, Ohkuma H
Brain Tumor Pathol 2018.7
-
Prototype screwdriver stopper to avoid intracranial penetration injury.
Asano K, Katayama K, Kakuta K, Ohkuma H
Neurosurg Rev 2018.7
-
The Effect of Goreisan on the Prevention of Chronic Subdural Hematoma Recurrence: Multi-Center Randomized Controlled Study.
Katayama K, Matsuda N, Kakuta K, Naraoka M, Takemura A, Hasegawa S, Akasaka K, Shimamura N, Itoh K, Asano K, Konno H, Ohkuma H
Journal of neurotrauma 35 ( 13 ) 1537 - 1542 2018.7
-
Importance and accuracy of intraoperative frozen section diagnosis of the resection margin for effective carmustine wafer implantation.
Asano K, Kurose A, Kamataki A, Kato N, Ogawa K, Katayama K, Kakuta K, Fumoto T, Ohkuma H
Brain tumor pathology 35 ( 3 ) 131 - 140 2018.7
-
Prototype screwdriver stopper to avoid intracranial penetration injury.
Asano K, Katayama K, Kakuta K, Ohkuma H
Neurosurgical review 41 ( 3 ) 895 - 898 2018.7
-
Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial.
Naraoka M, Matsuda N, Shimamura N, Asano K, Akasaka K, Takemura A, Hasegawa S, Ohkuma H
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 38 ( 7 ) 1190 - 1198 2018.7
-
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S, Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG).
Journal of neuro-oncology 138 ( 3 ) 627 - 636 2018.7
-
Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.
Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, Nagane M, Nakasu Y, Hashimoto N, Terasaki M, Matsumura A, Ishikawa E, Wakabayashi T, Iwadate Y, Ohue S, Kobayashi H, Kinoshita M, Asano K, Mukasa A, Tanaka K, Asai A, Nakamura H, Abe T, Muragaki Y, Iwasaki K, Aoki T, Watanabe T, Sasaki H, Izumoto S, Mizoguchi M, Matsuo T, Takeshima H, Hayashi M, Jokura H, Mizowaki T, Shimizu E, Shirato H, Tago M, Katayama H, Fukuda H, Shibui S, Japan Clinical Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology JCO2018786186 2018.6
-
Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.
Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, Nagane M, Nakasu Y, Hashimoto N, Terasaki M, Matsumura A, Ishikawa E, Wakabayashi T, Iwadate Y, Ohue S, Kobayashi H, Kinoshita M, Asano K, Mukasa A, Tanaka K, Asai A, Nakamura H, Abe T, Muragaki Y, Iwasaki K, Aoki T, Watanabe T, Sasaki H, Izumoto S, Mizoguchi M1, Matsuo T, Takeshima H, Hayashi M, Jokura H, Mizowaki T, Shimizu E, Shirato H, Tago M, Katayama H, Fukuda H, Shibui S
J Clin Oncol. 2018.6
-
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
Wakabayashi T, Natsume A, et al
J Neurooncol 2018.3
-
The effect of goreisan on the prevention of chronic subdural hematoma recurrence - multicenter, randomized controlled study.
Matsuda N, Kakuta K, Naraoka M, Takemura A, Hasegawa S, Akasaka K, Shimamura N, Itoh K, Asano K, Hiromu K, Ohkuma H.
J Neurotrauma 2018.2
-
Assessment of the Accuracy and Errors of Head-Up Display by an Optical Neuro-navigation Systemin Brain Tumor Surgery.
Asano K, Katayama K, Kakuta K, Oyama K, Ohkuma H.
Neurosurgery 12 ( 1 ) 23 - 35 2017.2